Healthtech Startups

Nexira supplies natural ingredients in powder form for food, beverage, health, and nutraceutical products, including plant-based extracts, fibers, proteins, and mineral compounds. The company sources, processes, and manufactures botanical and functional ingredients in its French facilities for use across functional beverages, supplements, sports nutrition, nutricosmetics, and food applications.

1 investor

Nexkin Medical designs and manufactures medical devices and systems for allergology testing. The company develops patient-centric digital health solutions aimed at improving allergy diagnosis and management.

1 investor

nexmed operates radiology centers offering imaging services such as MRI scans using 3-Tesla equipment, with a focus on patient service and consultation. It runs clinics in seven cities across the German states of North Rhine-Westphalia and Hesse.

1 investor

Nexmedis offers an AI-powered Health Information System (HIS) for medical facilities, including clinical decision support that suggests differential diagnoses and real-time patient data access. It also transcribes doctor-patient consultations in real time and organizes them into the SOAP framework.

1 investor

NextCell Pharma is a Swedish biotech company developing stem cell therapies (advanced therapy medicinal products) focused primarily on autoimmune and inflammatory diseases, with its lead candidate ProTrans targeting type 1 diabetes. The company operates three business areas — Cellaviva, ProTrans, and QVance — and runs Cellaviva, described as Scandinavia's largest stem cell bank.

1 investor

A biotechnology company developing patent-pending technology to combat antibiotic resistance by targeting bacterial resistance mechanisms and restoring the effectiveness of existing antibiotics.

1 investor

NextCare operates urgent care and occupational medical clinics across 12 US states, providing accessible healthcare services through multiple brands. The company manages over 150 clinical locations serving patients needing non-emergency medical care.

1 investor

NextGen Jane runs a longitudinal molecular study of women's menstruation, using an at-home organic cotton tampon collection kit that members mail in to derive genomic insights from uterine samples. The company aims to improve diagnostics and treatment for gynecological conditions such as endometriosis and other menstrual and reproductive health issues.

1 investor

NEXT NEW WORLD is a Japanese company developing silk protein technology, centered on its patented "Karada Silk" process that turns silk into a water-soluble solution while preserving its nano-scale porous structure for adsorption and cosmetic benefits. It applies this material to healthcare, food, cosmetics, and materials markets through joint research with universities and research institutions in Japan and abroad.

1 investor

NextPharma is a European contract development and manufacturing organization (CDMO) providing pharmaceutical development, clinical trials supply, commercial manufacturing and packaging, analytical and microbiological services, and food supplement production. It serves pharmaceutical and nutrition companies developing and manufacturing drugs and food supplements for worldwide markets.

1 investor

Nextrast develops medical imaging contrast agents, including a non-iodine 'blood-pool' agent that stays visible in vasculature and organs for extended imaging windows and an oral agent that darkens the bowel lumen to improve anatomic delineation. Its products target applications such as oncology, cardiovascular disease, inflammatory bowel disease, and small tumor detection.

1 investor

Nexus develops healthcare software solutions for hospitals, rehabilitation facilities, specialist clinics, and nursing homes, with a focus on sustainability and ESG principles. The company optimizes software for energy efficiency and process improvement to free up clinical staff for patient care.

1 investor

Nexus Day Hospitals operates specialised private hospital facilities in Australia that provide surgical and medical care in a patient-focused environment. The hospital network emphasizes personalised care delivery and exceptional patient experience.

1 investor

NexusMD provides an AI layer for clinicians and healthcare providers that uses generative AI to assist with clinical documentation, care continuity, and medical coding. It aims to reduce administrative workload so practitioners can focus more on patient care.

1 investor

NF2 Therapeutics (NF2Tx) is a biotech company developing therapies for neurofibromatosis 2 related schwannomatosis (NF2) and related disorders, including an antibody drug conjugate targeting meningiomas and an AAV-based gene therapy for vestibular schwannomas. It works with patients, physicians, and researchers to develop treatments for these rare genetic disorders.

1 investor

Nia Health develops indication-specific digital therapeutics (DTx) and digital health applications (DiGA) for patients with chronic skin and allergic conditions such as eczema, psoriasis and acne, with features including remote patient monitoring and clinical-trial data collection. Its software serves patients, dermatologists and pharma/healthcare partners, with reimbursement experience through German health insurers.

1 investor

NicMap Vision analyzes twenty years of market data on the senior housing sector, which it characterizes as broadly competitive and experiencing growth from demographic demand.

1 investor

NICO develops surgical devices for neurosurgery, including tools used in treating intracerebral hemorrhage (ICH) and fluorescence-guided surgery. Its products serve neurosurgeons and are supported by clinical trial data such as the ENRICH trial.

1 investor

Medical device company developing SEPIA for improved epicardial ablation of ventricular tachycardia. Acquired.

1 investor

Nightingale offers a digital respiratory management program for adults with asthma and COPD, combining a mobile app and wearable device that track health parameters from breathing and provide personalized lifestyle guidance. The subscription service also includes onboarding and regular sessions with respiratory therapists and health and wellness coaches.

1 investor

Nightingale is a clinical decision support application for providers who deliver evidence-based interventions to individuals with autism and related disorders, such as applied behavior analysis, speech-language pathology, and occupational therapy. It offers HIPAA-compliant tools for data collection, reporting, and analytics that can be customized to any curriculum and setting, serving autism service practitioners in the U.S.

1 investor

Nightingale provides web-based tools using machine learning and artificial intelligence to help hospital nursing teams optimize workforce operations, including staffing, scheduling, nurse-patient matching, hiring, training, and promotion. The platform analyzes nursing care data to improve patient safety, efficiency, and outcomes while reducing costs for health systems.

1 investor

NightWare is an FDA-cleared prescription digital therapeutic system designed to interrupt nightmares as they occur, improving sleep quality for patients with Nightmare Disorder, including those with PTSD. It is intended for physicians and patients seeking treatment for frequent, traumatic nightmares.

1 investor

This page lists third-party solution partners for NikoHealth, a platform serving the home medical equipment (HME/DME) industry. The partners provide services such as revenue cycle management, billing, staffing, medical supply distribution, accreditation, and document automation for HME/DME providers.

1 investor